Irene Vergilis-Kalner is a Dermatology physician affiliated with University Hospital. OpenAlex indexes 25 publications with 334 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2727 Ocean Pkwy Ste L1
Brooklyn, NY 112357848
Telephone
718-975-7546Registry record last updated 7 May 2015.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- Lilly USA, LLCProgram year20241 payment
- Incyte CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
93.5%Porphyrin Precursor93.5%Aminolevulinic acid hcl100%Part B, office-administered≥40 patientsDermatology
4.4%Corticosteroid3.4%Triamcinolone acetonide77%Triamcinolone Acetonide23%Part D + Part B≥83 patientsSulfonamide Antibacterial0.3%Silver Sulfadiazine100%Part D≥25 patients+ 4 more classes in this area
Anti-infectives
1%Azole Antifungal0.5%Ketoconazole100%Part D≥21 patientsLincosamide Antibacterial0.5%Clindamycin Phosphate100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genitalia2025
- Response to the possibility of the application of topical photodynamic therapy leading to development of more histologically aggressive subtypes of Basal cell carcinomas.
PubMed
2014 - The use of photodynamic therapy as chemoprevention for the treatment of actinic keratoses and reduction in the number of non-melanoma skin cancers.
PubMed
2013 - Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.
PubMed
2012
Similar KOLs
Other experts from the same institution or the same specialty.
James Donahoo, MD
University Hospital
Ran Rubinstein, M, D
University Hospital
Madeline Singer, MD
University Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”